CTLA-4: From conflict to clinic

被引：11
|
作者：
不详
机构：
来源：
JOURNAL OF EXPERIMENTAL MEDICINE | 2007年 / 204卷 / 06期
关键词：
D O I：
10.1084/jem.2046fta
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CTLA-4 was first identified in 1991 as a second receptor for the T cell costimulation ligand B7. Uncertainties about its biological function plagued the early years after its discovery until 1995, when it was confirmed to be an inhibitor of T cell responses. CTLA-4 has since scored in the clinic as a target for antitumor therapy and as a soluble inhibitor of autoimmunity.
引用
收藏
页码：1243 / 1243
页数：1
相关论文
共 50 条
  • [31] CTLA-4 trafficking and surface expression
    Valk, Elke
    Rudd, Christopher E.
    Schneider, Helga
    TRENDS IN IMMUNOLOGY, 2008, 29 (06) : 272 - 279
  • [32] A native soluble form of CTLA-4
    Oaks, MK
    Hallett, KM
    Penwell, RT
    Stauber, EC
    Warren, SJ
    Tector, AJ
    CELLULAR IMMUNOLOGY, 2000, 201 (02) : 144 - 153
  • [33] CTLA-4: a moving target in immunotherapy
    Rowshanravan, Behzad
    Halliday, Neil
    Sansom, David M.
    BLOOD, 2018, 131 (01) : 58 - 67
  • [34] The role of CTLA-4 in immune regulation
    Verhagen, Johan
    Sabatos, Catherine A.
    Wraith, David C.
    IMMUNOLOGY LETTERS, 2008, 115 (01) : 73 - 74
  • [35] CTLA-4 genotypes in systemic sclerosis
    Pander, JP
    Hudson, LL
    Silver, RM
    FASEB JOURNAL, 2003, 17 (07): : C179 - C179
  • [36] Thymosin α1 protects from CTLA-4 intestinal immunopathology
    Renga, Giorgia
    Bellet, Marina M.
    Pariano, Marilena
    Gargaro, Marco
    Stincardini, Claudia
    D'Onofrio, Fiorella
    Mosci, Paolo
    Brancorsini, Stefano
    Bartoli, Andrea
    Goldstein, Allan L.
    Garaci, Enrico
    Romani, Luigina
    Costantini, Claudio
    LIFE SCIENCE ALLIANCE, 2020, 3 (10)
  • [37] Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency
    Watson, Leisa Rebecca
    Slade, Charlotte A.
    Ojaimi, Samar
    Barnes, Sara
    Fedele, Pasquale
    Smith, Prudence
    Marum, Justine
    Lunke, Sebastian
    Stark, Zornitza
    Hunter, Matthew F.
    Bryant, Vanessa L.
    Low, Michael Sze Yuan
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2018, 14
  • [38] Current understanding of CTLA-4: from mechanism to autoimmune diseases
    Hossen, Md Munnaf
    Ma, Yanmei
    Yin, Zhihua
    Xia, Yuhao
    Du, Jing
    Huang, Jim Yi
    Huang, Jennifer Jin
    Zou, Linghua
    Ye, Zhizhong
    Huang, Zhong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [39] CTLA-4: Not All Costimulation Is Stimulatory
    Auchincloss, Hugh
    Turka, Laurence A.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (07): : 3457 - 3458
  • [40] CTLA-4 nanobody stops colitis
    Bernard, Nicholas J.
    NATURE IMMUNOLOGY, 2024, 25 (02) : 190 - 190
12345